Extremity Products Market Share

North American Market Forecast

The Extremity Products market in North America is predicted to account for the largest share of 46% by 2036 impelled by the rising spending in healthcare. As a result, more companies in the region are introducing advanced medical treatments and orthopedic interventions. Moreover, this has also improved access to medical services to meet the need of individuals who are suffering from orthopedic issues. According to estimates in 2o21, U.S. health spending climbed by over 2% to reach around USD 4 trillion, or USD 12,913 per person.

European Market Statistics

The Europe Extremity Products market is estimated to be the second largest, during the forecast timeframe led by the increasing mergers and acquisitions. For instance, in January 2021 Smith+Nephew a British multinational medical equipment manufacturing company acquired the Extremity Orthopaedics business of Integra LifeSciences Holdings Corporation to boost its extremities business by combining a complementary shoulder replacement and upper and lower extremities portfolio.

Frequently Asked Questions (FAQ)

The growing incidence of arthritis across the globe and the growing technological advancements in orthopedic implant technology are the major factors driving the growth of the market.

The market size of Extremity Products is anticipated to attain a CAGR of 7% over the forecast period, i.e., 2024-2036.

The major players in the market are Acumed LLC, Owens and Minor Inc., Skeletal Dynamics LLC, Smith and Nephew plc, TriMed Inc., Waldemar Link GmbH and Co. KG, Wright Medical Group NV, Zimmer Biomet Holdings Inc., Arthrex Inc., Stryker Corp., and others.

The upper extremities segment is anticipated to garner the largest market size by the end of 2036 and display significant growth opportunities.

The market in the North American region is projected to hold the largest market share by the end of 2036 and provide more business opportunities in the future.

Extremity Products Market Share